MedPath

Tart Cherries and Melatonin Content

Not Applicable
Completed
Conditions
Sleep
Interventions
Dietary Supplement: Fruit juice cordial
Dietary Supplement: Cherry juice
Registration Number
NCT01528202
Lead Sponsor
Northumbria University
Brief Summary

The aim of this investigation was to examine the effects of tart Montmorency cherry juice on urinary 6-sulfatoxymelatonin and sleep quality using a double-blind, placebo-controlled, cross-over design.

Detailed Description

The aim of the study is to examine the efficacy of tart cherry juice on sleep quality, quantity, and timing. Naturally circulating melatonin is instrumental in regulating sleep/wake schedules. Tart Montmorency cherries (Prunus Cerasus) contain high levels of melatonin and may be a useful intervention to supplement for realignment of circadian phase and by increasing the robustness of circadian amplitude. In normal healthy adults, with experimentally induced phase advanced circadian misalignment, the administration of a 3mg supplement of melatonin significantly increased sleep architecture characteristics. In this study we want to examine the efficacy of tart cherry juice in increasing urinary levels of melatonin and the subsequent impact this will have on sleep parameters.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Equal numbers of healthy, non-pathological males and females aged between 18-39.
Exclusion Criteria
  • history of epilepsy, current episode of major depressive disorder or anxiety disorder, or a current sleep problem or an inability to comprehend English, travel over two time zones within the last six months, excessive alcohol (over 3 units per day) or caffeine consumption (more than 6 caffeinated drinks or 1 after 6pm), a smoker, a shift worker, a familial history of diabetes, users of medication or supplements, or if the participant is pregnant or currently lactating.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboFruit juice cordialPlacebo intervention given after 'baseline placebo' arm
cherry juiceCherry juicetrial where cherry juice is taken following the 'baseline cherry juice' arm
Primary Outcome Measures
NameTimeMethod
urinary 6-sulphatoxymelatonincontinually for 48 hours

urinary 6-sulphatoxymelatonin is the primary metabolite of melatonin and provides a sarrogate marker of melatonin metabolism. By measuring over a 48 h period it is possible to examine the circadian rhythm of melatonin.

Secondary Outcome Measures
NameTimeMethod
Sleep qualitycontinually throughout the duration of the study

Acti watches quantitively measure sleep and activity of participants, whereas slep recall provides a retrospective and subjective m,easure of sleep quality.

Trial Locations

Locations (1)

Northumbria University

🇬🇧

Newcastle upon Tyne, Tyne and Wear, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath